Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23634639 | 0.93 | KDM4E (0.30) | KDM4EATML3MBTL1 | |
| SCHEMBL16390665 | 0.90 | MAPT (0.35) | KDM4EATML3MBTL1MAPT | |
| SCHEMBL23625811 | 0.88 | — | — | |
| SCHEMBL23634626 | 0.84 | MEN1 (0.31) | MEN1KMT2A | |
| SCHEMBL20128029 | 0.83 | KDM4E (0.35) | KDM4EATML3MBTL1MAPT | |
| SCHEMBL18101301 | 0.83 | TP53 (0.30) | — | |
| SCHEMBL26254537 | 0.82 | JAK2 (0.32) | KDM4EATML3MBTL1MAPT | |
| SCHEMBL26539699 | 0.81 | — | — | |
| SCHEMBL23625816 | 0.81 | LPL (0.32) | — | |
| SCHEMBL18101318 | 0.80 | KDM4E (0.35) | KDM4EATML3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11787818-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-11787818-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-20210206778-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787818-B2 | Compound and organic light emitting device comprising the same | NCOA4, RCOR1, NR2E3 | KDM4E 2322/4885ATM 2863/4885L3MBTL1 1271/4885 |
| US-20210206778-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | NCOA4, NR2E3, NR4A1 | KDM4E 2312/4885ATM 2659/4885L3MBTL1 1393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.